This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
There are many important things in healthcare that only a medical professional is capable of and AI cannot do, including but not limited to: empathizing with patients, feeling the joy of positive test results and sharing the heartbreak of negative, or exercising intuition honed over decades of experience treating patients in real-world clinical settings.
The American College of Radiology's (ACR) 2025 Radiology Leadership Institute (RLI) Emerging Leaders Scholarship now includes the Philips Executive Mentorship program. Residents and fellows who receive the award will benefit from a full scholarship to attend the 2025 RLI Summit, an array of other RLI programs, and a one-year, new Philips-led executive mentorship, the RLI said.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Telix Pharmaceuticals has entered into an asset purchase agreement with ImaginAb initially worth $45 million. Under terms of the deal, Telix will acquire a pipeline of therapeutic candidates such as DLL3 and integrin v6, a biologics technology platform, and a protein engineering and discovery research facility in California, it said. The new drug candidates will fit into Telix's existing therapeutics development, while the intellectual property it will acquire from ImaginAb will allow for specif
The U.S. Preventive Services Task Force (USPSTF) has placed a higher emphasis on the use of dual-energy x-ray absorptiometry (DEXA) for osteoporosis screening, according to an updated recommendation published January 14 in JAMA. For the current recommendation, the USPSTF has noted that screening includes [DEXA] bone mineral density (BMD), with or without fracture risk assessment, the task force wrote.
Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
PET imaging can assess brain metabolism changes over time in individuals with prodromal dementia with Lewy bodies (DLB) and probable DLB, according to a study published January 13 in JAMA Neurology. The finding is from a study that showed greater brain metabolic decline in patients with the disease than those without over 3.8 years, noted corresponding author Kejal Kantarci, MD, of the Mayo Clinic in Rochester, MN, and colleagues.
Although some form of neural superiority may not be the driving factor behind an elite athletes talent, new evidence shows these individuals have unique structure and connectivity patterns.
A machine learning (ML) model including both coronary CT angiography (CCTA) and stress cardiac MRI data can accurately predict major adverse cardiovascular events (MACE), suggest findings published January 14 in Radiology. Researchers led by Tho Pezel, MD, from Universit Paris Cit in France found that their model performed better than traditional methods and existing scores in patients with newly diagnosed coronary artery disease.
tim.hodson Mon, 01/13/2025 - 17:04 Jan. 10, 2024 ImagingU hasannounced the dates of its 2025 MRI Safety and MRSO Conferences. ImagingUs in-person weekend conferences are designed for current or aspiring MR Safety Officers, as well as other radiology professionals looking to increase their MRI safety knowledge or earn continuing education credits (CEUs).
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Pulmonary embolism (PE) is a complex and life-threatening condition that demands swift action and multidisciplinary collaboration. Pulmonary embolism response teams (PERTs) are a transformative innovation in PE care, providing a coordinated framework to improve clinical decision-making, streamline workflows and ultimately improve patient outcomes. Now, with AI-enabled tools, PERT teams are unlocking new levels of efficiency and effectiveness in PE management.
Sacramento, CA-based Sutter Health and GE HealthCare have entered a seven-year strategic enterprise partnership. Under the agreement, Sutter Health will deploy GE HealthCares AI-powered imaging and ultrasound technology across the entire healthcare system, including GE HealthCares Omni Legend PET/CT, StarGuide SPECT/CT, and Vscan Air SL ultrasound machines.
In a recent interview, Phillip Kuo, M.D., discussed the impact of newer anti-amyloid antibody therapies for Alzheimers disease upon recently issued appropriate use criteria (AUC) for amyloid positron emission tomography (PET) imaging as well as the incorporation of tau PET into the AUC for patients with mild cognitive impairment.
Berlin-based Ariceum Therapeutics has received investigational new drug clearance from the U.S. Food and Drug Administration (FDA) to launch a phase I/II clinical trial of a radiolabelled peptide that targets small cell lung cancer or Merkel Cell Carcinoma (MCC). The so-called SANTANA-225 trial will assess the safety, tolerability, preliminary efficacy, and recommended dose of actinium-225 (Ac-225) SSO110 in patients with extensive-stage SCLC or MCC who are on first-line maintenance therapy with
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Butterfly Network and Rutgers Robert Wood Johnson Medical School (RWJMS) are highlighting results from a study that investigated the impact of point-of-care ultrasound (POCUS) on hospital care. The findings were presented in December at the European Association of Cardiovascular Imaging's EchoEuro-Imaging Conference in Berlin, Germany. The study evaluated the use of cardiopulmonary POCUS for patients admitted to the hospital with shortness of breath without an identifiable cause and compared pat
Accuray has secured approval from the Chinese National Medical Products Administration (NMPA) for its Radixact SynC and CyberKnife S7 systems. The introduction of the Radixact SynC System marks the first approval in China for Accuray's ClearRT kVCT imaging and Synchrony technology, and CyberKnife S7 is the company's latest generation CyberKnife platform, according to the firm.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Pharmacists in community healthcare programs provide essential services, enhancing public health through education, collaboration, and improved care. The post Setting Up Community Healthcare Programs: How Pharmacists Can Help appeared first on Open MedScience.
International Isotopes has purchased 1.77 acres of land adjacent to its Idaho Falls facility. The lot can accommodate a facility that exceeds 50,000 square feet, it said. It has also entered into a lease agreement with the option to purchase a second building, which is located on 1.73 acres directly across the street from its Idaho Falls facility. This building is 8,600 square feet.
Cone Beam CT (CBCT) and traditional Computed Tomography (CT or CAT) are vital imaging technologies that serve distinct purposes in medical and dental diagnostics. While both rely on X-ray radiation to create detailed 3D images, their design, applications, and radiation exposure levels differ significantly.
ITM Isotope Technologies Munich SE and Ariceum Therapeutics have entered into an agreement under which ITM will supply Ariceum with actinium-225 (Ac-225) for that company's radiopharmaceutical therapies pipeline. ITM will provide Ariceum with Ac-225 produced by Actineer, its joint venture company with Canadian Nuclear Laboratories, it said. Ac-225 is a rare medical radioisotope used in radiopharmaceutical therapies for the treatment of various cancer indications, according to the firm.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content